Terms: = Lung cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Treatment
44 results:
1. CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses.
Lou H; Wu Z; Wei G
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186304
[TBL] [Abstract] [Full Text] [Related]
2. A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells.
Donnenberg VS; Luketich JD; Sultan I; Lister J; Bartlett DL; Ghosh S; Donnenberg AD
Front Immunol; 2023; 14():1157697. PubMed ID: 37063842
[TBL] [Abstract] [Full Text] [Related]
3. Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients.
Tozuka T; Yanagitani N; Yoshida H; Manabe R; Ogusu S; Tsugitomi R; Sakamoto H; Amino Y; Ariyasu R; Uchibori K; Kitazono S; Seike M; Gemma A; Nishio M
Invest New Drugs; 2023 Jun; 41(3):411-420. PubMed ID: 37058183
[TBL] [Abstract] [Full Text] [Related]
4. [Monitoring Blood Markers to Predict Nivolumab Effectiveness in Esophageal Carcinoma].
Funatsuya T; Tanaka Y; Honma M; Fukuoka H; Takahashi M
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1139-1141. PubMed ID: 36281612
[TBL] [Abstract] [Full Text] [Related]
5. A novel HIF1α-stil-FOXM1 axis regulates tumor metastasis.
Wang YW; Chen SC; Gu DL; Yeh YC; Tsai JJ; Yang KT; Jou YS; Chou TY; Tang TK
J Biomed Sci; 2022 Apr; 29(1):24. PubMed ID: 35365182
[TBL] [Abstract] [Full Text] [Related]
6. Development of a Magnetic Nanostructure for Co-delivery of Metformin and silibinin on Growth of lung cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation.
Salmani Javan E; Lotfi F; Jafari-Gharabaghlou D; Mousazadeh H; Dadashpour M; Zarghami N
Asian Pac J Cancer Prev; 2022 Feb; 23(2):519-527. PubMed ID: 35225464
[TBL] [Abstract] [Full Text] [Related]
7. Knockdown of stil suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway.
Wang J; Zhang Y; Dou Z; Jiang H; Wang Y; Gao X; Xin X
J Cell Mol Med; 2019 Aug; 23(8):5566-5575. PubMed ID: 31187582
[TBL] [Abstract] [Full Text] [Related]
8. A novel method for quantification of beam's-eye-view tumor tracking performance.
Hu YH; Myronakis M; Rottmann J; Wang A; Morf D; Shedlock D; Baturin P; Star-Lack J; Berbeco R
Med Phys; 2017 Nov; 44(11):5650-5659. PubMed ID: 28887836
[TBL] [Abstract] [Full Text] [Related]
9. IL-15/sil-15Rα gene transfer suppresses Lewis lung cancer growth in the lungs, liver and kidneys.
Sun H; Liu D
Cancer Gene Ther; 2016; 23(2-3):54-60. PubMed ID: 26742578
[TBL] [Abstract] [Full Text] [Related]
10. The anticancer effects of biodegradable nanomagnetic dual natural components on the leptin gene expression in lung cancer.
Askari S; Salehi R; Zarghami N; Akbarzadeh A; Rahmati-Yamchi M
Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1753-63. PubMed ID: 26593227
[TBL] [Abstract] [Full Text] [Related]
11. Urinary protein biomarkers in the early detection of lung cancer.
Nolen BM; Lomakin A; Marrangoni A; Velikokhatnaya L; Prosser D; Lokshin AE
Cancer Prev Res (Phila); 2015 Feb; 8(2):111-9. PubMed ID: 25416410
[TBL] [Abstract] [Full Text] [Related]
12. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract] [Full Text] [Related]
13. Markerless EPID image guided dynamic multi-leaf collimator tracking for lung tumors.
Rottmann J; Keall P; Berbeco R
Phys Med Biol; 2013 Jun; 58(12):4195-204. PubMed ID: 23715431
[TBL] [Abstract] [Full Text] [Related]
14. The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine.
Kao SC; Harvie R; Paturi F; Taylor R; Davey R; Abraham R; Clarke S; Marx G; Cullen M; Kerestes Z; Pavlakis N
Lung Cancer; 2012 Feb; 75(2):248-54. PubMed ID: 21757252
[TBL] [Abstract] [Full Text] [Related]
15. [Update regarding the role of biomarkers in early diagnosis of non-small cell bronchopulmonary cancer].
Dragomir A; Moldoveanu E; Mihălţan F
Pneumologia; 2011; 60(1):7, 9-13. PubMed ID: 21548194
[TBL] [Abstract] [Full Text] [Related]
16. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.
Berrington de Gonzalez A; Curtis RE; Gilbert E; Berg CD; Smith SA; Stovall M; Ron E
Br J Cancer; 2010 Jan; 102(1):220-6. PubMed ID: 19935795
[TBL] [Abstract] [Full Text] [Related]
17. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.
Bien E; Balcerska A
Biomarkers; 2008 Feb; 13(1):1-26. PubMed ID: 17906988
[TBL] [Abstract] [Full Text] [Related]
18. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
Pastorino F; Brignole C; Di Paolo D; Nico B; Pezzolo A; Marimpietri D; Pagnan G; Piccardi F; Cilli M; Longhi R; Ribatti D; Corti A; Allen TM; Ponzoni M
Cancer Res; 2006 Oct; 66(20):10073-82. PubMed ID: 17047071
[TBL] [Abstract] [Full Text] [Related]
19. Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib.
Kanazawa S; Yamaguchi K; Kinoshita Y; Komiyama Y; Muramatsu M; Nomura S
J Cancer Res Clin Oncol; 2006 Nov; 132(11):719-25. PubMed ID: 16835747
[TBL] [Abstract] [Full Text] [Related]
20. [Prognostic factors in patients with small cell lung cancer].
Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
[TBL] [Abstract] [Full Text] [Related]
[Next]
